apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Oct 9, 2024 | 10:52 AM IST

Ryverna 10Mg/ml Inj is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease. It contains Crizanlizumab-tmca, which works by binding to the protein P-selectin in the blood. This protein is responsible for the adhesion of blood cells. By inhibiting P-selectin, blood cell limitations are avoided, and blood supply throughout the body is improved. Common side effects of this medicine may include Infusion site reactions, nausea, arthralgia (pain in a joint), back pain, and pyrexia (fever).

Read more
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Synonym

CRIZANLIZUMAB-TMCA

Manufacturer/Marketer

Novartis India Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About Ryverna 10Mg/ml Inj

Ryverna 10Mg/ml Inj belongs to the group of medicines called monoclonal antibodies, which is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease. A vaso-occlusive crisis, or VOC, occurs when sickled red blood cells obstruct blood flow to the point where tissues are deprived of oxygen. This, in turn, causes an inflammatory reaction. The outcome is severe pain, which can affect any part of the body but is most typically felt in the back, chest, or extremities.

Ryverna 10Mg/ml Inj contains Crizanlizumab-tmca, which works by blocking certain blood cells from interacting.

Ryverna 10Mg/ml Inj will be administered by a healthcare professional; do not self-administer. Your doctor will decide the dose and duration based on your medical condition. In some cases, Ryverna 10Mg/ml Inj may cause Infusion site reactions, nausea, arthralgia (pain in a joint), back pain, and pyrexia (fever). Most of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen.

Before taking the Ryverna 10Mg/ml Inj, let your doctor know about all your medical conditions, sensitivities, and medications you are using. Ryverna 10Mg/ml Inj may cause fetal harm. So, inform your doctor if you are pregnant and planning to become pregnant. Do not breastfeed while on medication unless recommended by the doctor. Ryverna 10Mg/ml Inj is not recommended for children below 16 years as the safety and effectiveness have not been established. Consumption of alcohol is not recommended while on therapy.

Uses of Ryverna 10Mg/ml Inj

Treatment of Vaso-Occlusive Crises (VOCs)

Medicinal Benefits

Ryverna 10Mg/ml Inj contains Crizanlizumab-tmca, which belongs to the group of medicines called monoclonal antibodies and is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients aged 16 years and older with sickle cell disease. Crizanlizumab-tmca which works by binding to the protein P-selectin in the blood. This protein is responsible for the adhesion of blood cells. By inhibiting P-selectin, blood cell limitations are avoided, and blood supply throughout the body is improved.

Directions for Use

Ryverna 10Mg/ml Inj will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Ryverna 10Mg/ml Inj

  • Infusion site reactions
  • Nausea
  • Arthralgia (pain in a joint)
  • Back pain
  • Pyrexia (fever)

Drug Warnings

Before using the Ryverna 10Mg/ml Inj, inform your doctor about your medical conditions (e.g., pregnancy, nursing, any scheduled surgery, etc.), sensitivities (allergic reactions to foods and medicines), and medications you are taking. Other drugs (especially corticosteroids) or supplements should not be taken with Ryverna 10Mg/ml Inj unless prescribed by a doctor. Do not miss any doses and finish the entire course of medicine. Stopping the drug too soon may cause the infection to reoccur or worsen.

Drug Interactions

Drug-Drug Interactions: Ryverna 10Mg/ml Inj may interact with a medication used to treat a certain form of myasthenia gravis (Efgartigimod alfa, Rozanolixizumab) and corticosteroid medications.

Drug-Food Interactions: Avoid the consumption of alcohol while taking Ryverna 10Mg/ml Inj.

Drug-Disease Interactions: Caution is advised if used Ryverna 10Mg/ml Inj in patients with renal or hepatic impairment.

Drug-Drug Interactions Checker List

  • EFGARTIGIMOD ALFA
  • ROZANOLIXIZUMAB

Habit Forming

No

Diet & Lifestyle Advise

  • A healthy diet is good for everyone, but it's especially crucial for those with sickle cell disease (SCD). Low levels of important nutrients such as proteins, minerals, and vitamins have been related to SCD.
  • Adopting a diet that is high in protein and other nutrients can help lessen discomfort and other SCD consequences.
  • Sickle cell disease patients should drink 8 to 10 glasses of water every day and eat nutritious foods. Try to stay cool, chilly, and energized.
  • A healthy diet high in zinc, folate, and water may assist in reducing the condition's consequences.

Special Advise

  • Platelet Counts should be evaluated on a regular basis throughout Ryverna 10Mg/ml Inj treatment and until full recovery is achieved.

Disease/Condition Glossary

A vaso-occlusive crisis, or VOC, occurs when sickled red blood cells obstruct blood flow to the point where tissues are deprived of oxygen. This, in turn, causes an inflammatory reaction. The outcome is severe pain, which can affect any body part but is most typically felt in the back, chest, or extremities.

bannner image

Alcohol

Caution

You are recommended to avoid alcohol consumption while taking Ryverna 10Mg/ml Inj. It could lead to unpleasant side effects.

bannner image

Pregnancy

Caution

Ryverna 10Mg/ml Inj may cause fetal harm. Therefore, please inform your doctor if you are pregnant; your doctor will weigh the benefits and potential risks before prescribing this medicine.

bannner image

Breast Feeding

Caution

It is not known if this medicine passes into your breast milk. Inform your doctor if you are breastfeeding or plan to breastfeed. Your doctor decides the best way to feed your baby during treatment with Ryverna 10Mg/ml Inj.

bannner image

Driving

Caution

Ryverna 10Mg/ml Inj does not impact your ability to drive or use machinery.

bannner image

Liver

Caution

Caution should be exercised while using Ryverna 10Mg/ml Inj in patients with liver disease. So, inform your doctor before receiving the Ryverna 10Mg/ml Inj if you have a history of liver diseases/conditions. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Kidney

Caution

Caution should be exercised while using Ryverna 10Mg/ml Inj in patients with kidney disease. So, inform your doctor before receiving the Ryverna 10Mg/ml Inj if you have a history of kidney diseases/conditions. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Children

Unsafe

Ryverna 10Mg/ml Inj is not recommended for children below 16 years as the safety and effectiveness have not been established.

Country of origin

India

Manufacturer/Marketer address

Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Other Info - RYV0002

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Ryverna 10Mg/ml Inj is used to treat Vaso-Occlusive Crises (VOCs).
Ryverna 10Mg/ml Inj contains Crizanlizumab-tmca which works by binding to the protein P-selectin in the blood. This protein is responsible for the adhesion of blood cells. By inhibiting P-selectin, blood cell limitations are avoided, and blood supply throughout the body is improved.
Infusion-related reactions may develop in some circumstances. If you experience any signs and symptoms, your doctor will discontinue the infusion and take necessary action accordingly.
Sickle cell disease is caused by a gene that alters the development of red blood cells.
No, it is indicated to reduce the frequency of vaso-occlusive crises (VOCs) with sickle cell disease.
The only cure for sickle cell disease is a stem cell or bone marrow transplant, which is rarely performed due to the complications involved.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.